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a b s t r a c t
Introduction: Migraine is a common neurological disorder characterized by a particular
phenotype, complex pathophysiology and a heterogeneous genetic background. Among
several heritable forms, familial hemiplegic migraine is the best described one. In the
majority of cases it is caused by mutations in one of three different genes.
Case report: Clinical symptoms of a 47 year old proband (and independently described in his
20 year old son) as well as differential diagnosis are discussed in the presented report. The
most characteristic were recurrent attacks of blurred vision, paresthesias and hemiparesis
often accompanied by speech disturbances and followed by severe headache with vomiting.
Advanced morphological and genetic procedures were required to exclude MELAS, CADASIL
and Call-Fleming syndrome. Finally, the deﬁnite diagnosis was possible after the application
of the whole exome sequencing technique. It conﬁrmed, for the ﬁrst time in the Polish
population, a heterozygous T666M mutation (c.1997C>T; p.Thr666Met) in the CACNA1A gene
in the proband, the proband's son and in several other family members.
Conclusion: The presented report provides clinical and genetic insight into familial hemiple-
gic migraine 1 resulting from a mutation in the CACNA1A gene.
© 2017 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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Migraine usually affects persons between the ages of 22 and
55 years and is considered to be one of the most common
neurological disorders worldwide. It is estimated that about
17% of females and 8% of males in Europe suffer from migraine
[1]. Familial hemiplegic migraine (FHM) was the ﬁrst geneti-
cally conﬁrmed heritable migraine described in the literature.
Three subtypes of familial hemiplegic migraine have been
identiﬁed. Familial hemiplegic migraine 1 (FHM1) is caused by
mutations in the pore-forming a1 subunit of the P/Q type
calcium channel (CACNA1A). FHM2 (ATP1A2) results from
mutations in the a2 subunit of the Na+/K+-ATPase pump, while
FHM3 (SCN1A) from mutations in the a1 subunit of the
neuronal voltage-gated Nav1.1 channel. Further genetic
analyses provided evidence of other genes involved in
migraine pathogenesis and explained neuronal hyperexcit-
ability of the migraine brain [2].
Familial hemiplegic migraine is an autosomal dominant
disorder which typically begins in the ﬁrst or second decade of
life [3]. Recurrent migraine attacks are usually preceded by
aura. Attacks are characterized by unilateral motor weakness
which lasts from minutes to days or even weeks and are
accompanied or followed by headache. Rarely a decreased
level of consciousness or fever are observed during the attacks.
Detailed family history should reveal similar symptoms in
close relatives. It is estimated that about 50% of cases are
accompanied by progressive cerebellar syndrome. FHM should
be always differentiated with epilepsy and postictal paresis
and with numerous other syndromes such as cerebral
autosomal dominant arteriopathy with subcortical infarcts
and leukoencephalopathy (CADASIL), mitochondrial encepha-
lomyopathy, lactic acidosis, and stroke-like episodes (MELAS),
hereditary hemorrhagic teleangiectasia, hereditary amyloid
angiopathy, familial cerebral cavernous malformation and
benign familial infantile convulsions [3]. Population studies in
Denmark estimated the prevalence of FHM as 0.01% with
predominance in women. FHM begins in the ﬁrst decade of life.
According to one publication, mutations in three genes,
CACNA1A, ATP1A2 and SCN1A account for about 50–70% ofFig. 1 – Pedigree of the family with T666M mutation in the CACN
presence of a mutation or lack thereof, respectively. Proband (IVfamilial cases and about 50% of cases are caused by mutations
in the CACNA1A gene [3]. Studies in Denmark gave different
results, only 14% of FHM families harbored mutations in the
CACNA1A and ATP1A2 genes [4].
2. Patients and methods
2.1. Proband
A 47 year old man (IV:12, Fig. 1) was for the ﬁrst time admitted
to our hospital in 2012. From 19 years of age he suffered from
episodes of blurred vision, paresthesia and hemiparesis of left
or right side sometimes accompanied by speech disturbances
and followed by severe headache with vomiting. Till 2012 he
was hospitalized several times in several neurological depart-
ments and many diagnoses were considered including
mitochondrial encephalomyopathy, familial hemiplegic mi-
graine and Call-Fleming syndrome.
At admission neurological examination revealed a high
arched palate, horizontal nystagmus, mild dysarthria, discrete
weakness and atrophy of forearm muscles, discreet left-sided
ataxia, positive Romberg test and gait on expanded base.
Routine laboratory tests were normal despite mild hypercho-
lesterolemia (total cholesterol level 232 mg/dl, normal range
120–200 mg/dl), hypertrigliceridemia (382 mg/dl, normal range
50–150 mg/dl) and slightly reduced vitamin B12 level (178.8 pg/
ml, normal range 191–663 pg/ml). Additionally in studies
performed a few years earlier elevated blood lactate level and
slightly increased cerebrospinal ﬂuid protein level (47 mg/dl,
normal range 15–45 mg/dl) were detected. Magnetic resonance
imaging (MRI) showed on T2-weighted and FLAIR images
numerous disseminated hyperintensive lesions in both hemi-
spheres and moderate cortical and subcortical atrophy with
marked cerebellum atrophy and slight enlargement of
ventricular system (Fig. 2a–c). There was no progression
comparing to the previous radiological studies. Additionally,
magnetic resonance spectroscopy revealed unspeciﬁc de-
crease of N-acetylaspartate in the cingulate gyrus. Magnetic
resonance angiography was normal. Initially Call–Fleming
syndrome was suspected, however, the reversible cerebralA1A gene: I–V indicate generations, ‘‘+’’ or ‘‘S’’ indicate the
:12) marked by an arrow.
Fig. 2 – Proband's brain MRI: (a, b) diffused hyperintensive lesions in both hemispheres on FLAIR images; (c) cerebellum
atrophy on T2-weighted image.
Fig. 3 – Proband's skeletal muscle. Capillary vessel with
swollen endothelial cell considerably narrowing vessel
lumen, and swollen pericyte processes. The affected cells
show clear cytoplasm, enlarged mitochondria and
distended endoplasmic reticulum. Bar 500 nm.
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exercise. Ultrasound Doppler examination was normal apart
from small atherosclerotic plaques in the bifurcation of
common carotid arteries and in the interior carotid arteries.
Echocardiography presented no abnormalities. Visual as well
as brain stem auditory evoked potentials were normal. Both
nerve conduction studies and electromyography (EMG) of
biceps brachii and vastus lateralis muscles were normal.
Electroencephalography (EEG) showed generalized epileptic
discharges more pronounced in the left hemisphere. Only mild
difﬁculties in learning and decreased direct memory were
found on neuropsychological assessment. Skeletal muscle
biopsy was performed twice, however, neither showed
characteristic abnormalities and ragged-red ﬁbers were not
found.
Previous genetic studies excluded mutations in the NOTCH3
gene, responsible for cerebral autosomal dominant arterio-
pathy with subcortical infarcts and leukoencephalopathy
(CADASIL). In addition to the genetic studies detailed
ultrastructural examination of vessels in muscle biopsy
material was performed. It also excluded CADASIL but
revealed numerous abnormal microvessels with pale, swollen
endothelial cells and pericytes (Fig. 3). Edema of the former
frequently considerably narrowed the vessel lumen. Affected
cells showed clear cytoplasm, enlarged mitochondria, dis-
tended endoplasmic reticulum and abundant vacuolar struc-
tures.
2.2. Proband's son
The 20 year old man (V:3, Fig. 1) was hospitalized for the ﬁrst
time at the age of 8 years. He was born in 37 hbd, with
hypotrophy (birth weight 1650 g) and he had 8 points on the
Apgar scale. Nevertheless, later psychomotor development
was normal. From the ﬁfth year of age he suffered from
recurrent paroxysmal episodes of intermittent aphasia,
hemiparesis and paresthesia accompanied by headache and
vomiting. Between the episodes neurological examination was
normal. Blood tests showed an elevated lactate level. Brain
magnetic resonance imaging showed on T2-weighted andFLAIR images disseminated hyperintensive lesions in both
hemispheres. Both MRI angiography and spectroscopy exclud-
ed other speciﬁc abnormalities. At the age of 12 the occlusion
of patent foramen ovale was performed. Electroencephalogra-
phy examination showed generalized epileptic discharges
both during neurological episodes and between them. Nerve
conduction studies were normal and EMG showed myopathic
changes in the biceps brachii muscle. To diagnose suspected
mitochondrial encephalomyopathy a skeletal muscle biopsy
was performed. Both histopathological and histochemical
studies of the muscle sample presented no abnormalities.
Ultrastructural examination of blood vessels in the skeletal
muscle biopsy showed the same type of abnormalities as in
the proband but of lesser severity (Fig. 4). Additionally
spectrophotometric analysis of electron transport chain
complexes did not detect any disturbances.
Fig. 5 – The T666M (c.1997C>T; p.Thr666Met) mutation in
CACNA1A gene (RefSeq:NM_001127221.1) detected using
whole-exome sequencing (WES). The analysis was
performed using a Nextera Rapid Capture Exome kit
(Illumina, San Diego, CA, USA) on the HiSeq 1500 according
to the manufacturer's protocol.
Fig. 4 – Proband's son's skeletal muscle. In capillary vessel
visible moderately swollen endothelial cell with cytoplasm
paler than nearby normal cell. Bar 500 nm.
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Detailed family history disclosed that similar symptoms were
recorded in 16 other family members, 12 men and 4 women.
The presented family pedigree suggested autosomal dominant
inheritance (Fig. 1).
2.4. Molecular study
Genetic studies toward mitochondrial encephalomyopathies
were done in the proband and his son. Whole exome
sequencing (WES) was performed as described previously [5].
3. Results and discussion
Molecular diagnosis toward mitochondrial encephalomyopa-
thies in the proband revealed only the presence of a single
mitochondrial DNA deletion with a low level of heteroplasmy
in the muscle tissue. No mutations were detected in coding
region of POLG and C10orf2 genes. In the proband's son all the
most common point mutations and mitochondrial DNA
deletions were excluded by appropriate tests in blood. WES
was performed in an arbitrarily chosen member of the family
(III:16) to look for a candidate gene. The study revealed a
known heterozygous T666M mutation in the CACNA1A gene
(Fig. 5). The linkage of the T666M variant with the disease in
the family was assessed by Sanger sequencing in 8 individuals,
including the proband, his son and individual III:16 (Fig. 1). The
heterozygous T666M mutation in the CACNA1A gene was
detected in the proband (IV:12) and all affected relatives
studied: the son (V:3), the proband's mother (III:6) and his four
cousins (III:1, III:10, III:16, IV:23). The mutation was not
detected in the healthy father of the proband (III:5). Till now
blood samples from other family members are not available.
The presented study of a ﬁrst to our knowledge Polish
family with the heterozygous T666M mutation (c.1997C>T;
p.Thr666Met) in the CACNA1A gene involved a comprehensiveand long lasting diagnostic work-up. The conﬁrmed mutation
was previously described in the literature, however, until
recently such genetic studies were not available apart from
strictly scientiﬁc purposes. Due to whole exome sequencing
the deﬁnite diagnosis was made. The proband's migraine with
transient hemiparesis as well as cerebellum atrophy and
episodic ataxia were comparable to those previously described
in the literature. In the meantime, several other hereditary
disorders were excluded in our patient. Although generally
mitochondrial disorders are maternally inherited, we consid-
ered the co-existence of multiple deletions or mitochondrial
DNA depletion syndrome followed by the mutation in one of
the nuclear genes responsible for imbalance of the respiratory
chain. However, neither skeletal muscle biopsy nor further
genetic analysis conﬁrmed that. It is worth mentioning that an
elevated lactate level is not speciﬁc and does not exclusively
indicate a mitochondrial disorder. It may be connected with
various conditions, for example with ischemic brain injury,
epilepsy, encephalitis and with mitochondrial disorders. The
most indicative for the ﬁnal clinical diagnosis of FHM1 were
episodes of paroxysmal and transient neurological deﬁcits,
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drial disorders are heterogeneous and highly variable even
within one family with the same mutation. Additionally,
symptoms are usually aggravated by infections, stressful
situations and exercise. In the presented case the episodes
were not correlated with any of the above conditions.
According to the literature data, recurrent and transient
attacks of hemiparesis and paresthesias in several family
members are the most characteristic for familial hemiplegic
migraine. In single cases triggering coexistence with fever was
reported, however, in all situations the patients recovered
completely [6]. For many years patients were often suspected
of having epilepsy rather than suffering from any genetic
disorder and antiepileptic drugs were administered. Brain
atrophy, especially in the cerebellum was reported in the
literature and correlated with migraine-induced ischemic
injury and not always with the disease duration [6]. In our
case hyperintensive lesions were noted both in the proband's
and his son's brain MRI, however, cerebellum atrophy was
observed only in the proband's MRI (Fig. 2c). Chronic and
progressive cerebellar ataxia was reported independently from
migraine attacks. Among additional clinical features epileptic
seizures and mental retardation were documented [7]. Several
different mutations in the CACNA1A gene were also identiﬁed
in episodic ataxia type 2 (EA-2) and spinocerebellar ataxia type
6 (SCA6) partially explaining the overlapping syndromes in
some families [8,9]. However, the T666M mutation was almost
exclusively associated with FHM1 with progressive cerebellar
ataxia phenotype. The recurrence of cerebellar symptoms was
observed in at least 20% of affected families [10,11]. Partial
efﬁcacy of acetazolamide in preventing paroxysmal attacks
was also reported in FMH1 cases [10]. Extensive studies of the
clinical spectrum of 117 patients with familial hemiplegic
migraine revealed that symptoms usually started at a young
age of about 11.7 years with a range from 1 to 51 years [12].
Moreover, the T666M mutation was more often associated
with hemiplegic migraine, severe attacks with coma and
nystagmus [12]. Taking all data into account in patients with
the same mutation clinical variability was marked, which
suggested the inﬂuence of other genetic or environmental
factors [12]. Similar ﬁndings were obtained by other groups,
for example from Korean patient studies [13]. They indicated
even the absence of headache in some cases and generally
strongly heterogeneous phenotypes and a meaningful role of
neuroimaging studies. Abnormalities described on MRI are
usually nonspeciﬁc, however, cerebellar atrophy as well as
disturbances in cerebral blood ﬂow during incidents were
frequent [13].
Ultrastructural examination of vessels in the proband's and
his son's muscle biopsies revealed pathological changes in
microvessels resembling onkosis. Three of the six different
types of voltage-gated calcium channels are known to be
present in vessels: high-voltage activated L- and P/Q-type
channels, and low-voltage activated T-type channel [14]. In the
brain, P/Q-type calcium channels are mainly located in
presynaptic terminals of neurons. However, there is growing
evidence that they could be also present in the cerebral
vasculature [15]. In familiar hemiplegic migraine with
CACNA1A gene mutation altered channels open more easily
than usual leading to increased cell inﬂux of calcium ions andaffecting endoplasmic reticulum and mitochondrial calcium
concentrations [16]. Therefore ultrastructural abnormalities in
cytoplasmic organelles and edema of vessel wall cells
observed by us may be either a direct consequence of disturbed
calcium inﬂux or a manifestation of secondary damage due to
increased susceptibility of vessels to glutaminergic transmis-
sion and/or cortical spreading depression.
Despite numerous studies, the deﬁnite pathogenesis of
migraine is still not known. Among heritable forms, only in a
few monogenic syndromes the direct genetic factors have
been recognized [17]. Therefore, a wide collaboration is needed
in order to identify different forms of migraine, its genetic
background and pathogenesis.
4. Conclusions
Familial hemiplegic migraine is one of the monogenic
autosomal dominant forms of migraine. Its comprehensive
phenotype requires variable diagnostic procedures to exclude
other conditions and establish a ﬁnal diagnosis. Detailed
family history and advanced genetic techniques are crucial
tools both in diagnostic work-up and in better understanding




We obtained written informed consent from the proband and
proband's son for publication of this case report and any
accompanying images. A copy of the written consents is
available for review by the corresponding author.
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